臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"高銘欽 ming ching kao"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 86-110 / 135 (共6页)
<< < 1 2 3 4 5 6 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
中國醫藥大學	2006-07-19	supression of colorectal tumor growth by Ganoderma tsugae extract causes G2/M arrest	高銘欽(Ming-Ching Kao)*; 許世忠(Shih-Chung Hsu); 王文奇(Vinchi Wang); 莊子超(Tzu-Chao Chuang); 劉嘉燿(Jia-Yaw Liu); 陳精祥(Chin-Shiung Chen); 林松洲(Sun-Chow Lin)
中國醫藥大學	2006-03	Increasing ornithine decarboxylase activity is another way of prolactin preventing methotrexate-induced apoptosis: crosstalk between ODC and BCL-2	(Hsu PC); (Hour TC); (Liao YF); (Hung YC); (Liu CC); (Chang WH); 高銘欽(Ming-Ching Kao); (Tsay GJ); (Hung HC); (Liu GY)*
中國醫藥大學	2006-01	Gene Transfer Mediated by Sphingosine/Dioleoylphosphatidylethanolamine Liposomes in the Presence of Poloxamer 188	(Law SL); (Chuang TC); 高銘欽(Ming-Ching Kao); (Lin YS); (Huang KJ)
中國醫藥大學	2005-12-31	臺灣栽培靈芝在血管增生抑制效能上之癌症治療研究	高銘欽(Ming-Ching Kao)
中國醫藥大學	2005-08	Ornithine decarboxylase prevents methotrexate-induced apoptosis by reducing intracellular reactive oxygen species production	(Huang CC); (Hsu PC); (Hung YC); (Liao YF); (Liu CC); (Hour CT); 高銘欽(Ming-Ching Kao); (Tsay GJ); (Hung HC); (Liu GY)*
中國醫藥大學	2005-07-31	卵巢癌基因治療--微脂粒媒介病毒核抗原抑制卵巢癌患者癌細胞生長之動物試驗	劉嘉燿(Jha-Yao Liu); 高銘欽(Ming-Ching Kao)
中國醫藥大學	2005-07-31	Gene chip approach to the molecular mechanism of repression of HER2/neu by the N-terminal domain of SV40 large T antigen	高銘欽(Ming-Ching Kao); 姜淑媛(Su-Yuan Jiang)
中國醫藥大學	2005-07	Nitric oxide induces prion protein via MEK and p38 MAPK signaling	(Wang V); (Chuang TC); (Hsu YD); (Chou WY); 高銘欽(Ming-Ching Kao)*
中國醫藥大學	2005-04-16	Human MnSOD suppresses HER2/neu-mediated breast cancer malignancy	高銘欽(Ming-Ching Kao)*; 莊子超(Tzu-Chao Chuang); 湯雅婷(Ya-Ting Tan); 林彥杏(Yeng-Shing Lin); 劉嘉燿(Jia-Yaw Liu); 林棋財(Chi-Tsai Lin)
中國醫藥大學	2005-04	Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan	(Li JW); (Chuang TC); (Yang AH); (Hsu CK); 高銘欽(Ming-Ching Kao)*
中國醫藥大學	2005-02	Skeletal muscle dihydropyridine-sensitive calcium channel (CACNA1S) gene mutations in chinese patients with hypokalemic periodic paralysis	(Lin SH)*; (Hsu YD); (Cheng NL); 高銘欽(Ming-Ching Kao)
中國醫藥大學	2005-01	Degradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu-overexpressing breast cancer cells	魏宗德; 高銘欽(Ming-Ching Kao); (Lin JK)
中國醫藥大學	2004-12-31	台灣本土栽培靈芝在抗癌保健作用的效益評估	高銘欽(Ming-Ching Kao)
中國醫藥大學	2004-11-09	Oncogene-targeting cancer gene therapy	高銘欽(Ming-Ching Kao)*
中國醫藥大學	2004-09	Black tea polyphenol theaflavins inhibit aromatase activity and attenuate tamoxifen resistance in HER2/neu-transfected human breast cancer cells through tyrosine kinase suppression.	魏宗德; (Lee HH); 高銘欽(Ming-Ching Kao); (Lin JK)
中國醫藥大學	2004-07-31	Gene chip approach to the molecular mechanism of repression of HER2/neu by the Epstein-Barr virus nuclear antigen-1	高銘欽(Ming-Ching Kao)
中國醫藥大學	2004-06-12	Suppression of HER2/neu by superoxide dismutase in breast cancer MDA-MB-453 cells	高銘欽(Ming-Ching Kao)*; 莊子超(Tzu-Chao Chuang); 湯(Ya-Ting Tan); 林(Yeng-Shing Lin); 林棋財(Chi-Tsai Lin)
中國醫藥大學	2004-02	Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway	魏宗德(Tzong-Der Way); 高銘欽(Ming-Ching Kao); 林仁混(Lin JK)*
中國醫藥大學	2003-11-07	The N-terminal domain only of EBNA1 as a tumor suppressor	高銘欽(Ming-Ching Kao)*; 莊子超(Tzu-Chao Chuang); 胡誌麟(Chih-Lin Hu); 林彥杏(Yeng-Shing Lin); 劉嘉燿(Jia-Yaw Liu); 羅世農(Sai-Lung Law)
中國醫藥大學	2003-08	EBNA1 may prolong G2/M phase and sensitize HER2/neu-overexpressing ovarian cancer cells to both topoisomerase II-targeting and paclitaxel drugs	(Chuang TC); (Lee YJ); (Liu JY); (Lin YS); (Lee JW); (Wang V); (Law SL); 高銘欽(Ming-Ching Kao)*
中國醫藥大學	2003-08	EBNA1 may prolong G(2)/M phase and sensitize HER2/neu-overexpressing ovarian cancer cells to both topoisomerase II-targeting and paclitaxel drugs	(Chuang TC); (Lee YJ); (Liu JY); (Lin YS); (Li JW); (Wang V); (Law SL); 高銘欽(Ming-Ching Kao)*
中國醫藥大學	2003-07-31	Evaluation of cancer gene therapy using the N-terminal domain of SV40 large T antigen through transgenic technology	高銘欽(Ming-Ching Kao)
中國醫藥大學	2003-05	Two novel thiazide-sensitive Na-Cl cotransporter mutations in a Chinese patient with Giteman's Syndrome presenting as hypokalemic paralysis	(Cheng NL); 高銘欽(Ming-Ching Kao); (Hsu YD); (Lin SH)*
中國醫藥大學	2002-11-17	The N-terminal domain only of EBNA1 may act as atransforming suppressor of theHER2/neu oncogene in ovarian cancers	高銘欽(Ming-Ching Kao)*
中國醫藥大學	2002-11	The Epstein–Barr virus nuclear antigen-1 may act as a transforming suppressor of the HER2/neu oncogene	(Chuang TC); 魏宗德; (Lin YS); (Lee YC); (Law SL); 高銘欽(Ming-Ching Kao)*

显示项目 86-110 / 135 (共6页)
<< < 1 2 3 4 5 6 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :0
	造访人次 : 51149296 在线人数 : 699 教育部委托研究计画计画执行:国立台湾大学图书馆